References
- Global strategy for asthma management and prevention. 2020. https://ginasthma.org/wp-content/uploads/2020/04/GINA-2020-full-report_-final-_wms.pdf. [last accessed 2 February 2021].
- Thomson NC, Chaudhuri R. Asthma in smokers: challenges and opportunities. Curr Opin Pulm Med. 2009;15(1):39–45. doi:https://doi.org/10.1097/MCP.0b013e32831da894.
- Yildiz F, Dursun AB, Disçi R. Prevalence of asthmatic smokers: Turkish experience (PASTE Study). Clin Respir J. 2014;8(3):350–356. doi:https://doi.org/10.1111/crj.12079.
- Sprio AE, Ciprandi G, Riccardi E, Giannoccaro F, Carriero V, Bertolini F, Ricciardolo FLM. The influence of smoking on asthma in the real-life. Respir Med. 2020;170:106066. doi:https://doi.org/10.1016/j.rmed.2020.106066.
- Tommola M, Ilmarinen P, Tuomisto LE, Haanpää J, Kankaanranta T, Niemelä O, Kankaanranta H. The effect of smoking on lung function: a clinical study of adult-onset asthma. Eur Respir J. 2016;48(5):1298–1306. doi:https://doi.org/10.1183/13993003.00850-2016.
- Thomson NC, Chaudhuri R, Heaney LG, Bucknall C, Niven RM, Brightling CE, Menzies-Gow AN, Mansur AH, McSharry C. Clinical outcomes and inflammatory biomarkers in current smokers and exsmokers with severe asthma. J Allergy Clin Immunol. 2013;131(4):1008. doi:10.1016./j.jaci.2012.12.1574.
- Aanerud M, Carsin A-E, Sunyer J, Dratva J, Gislason T, Jarvis D, deMarco R, Raherison C, Wjst M, Dharmage SC, et al. Interaction between asthma and smoking increases the risk of adult airway obstruction. Eur Respir J. 2015;45(3):635–643. doi:https://doi.org/10.1183/09031936.00055514.
- TS, Hallstrand WR. HendersonJr. An update on the role of leukotrienes in asthma. Curr Opin Allergy Clin Immunol. 2010;10(1):60–66. doi:https://doi.org/10.1097/ACI.0b013e32833489c3.
- Devillier P, Baccard N, Advenier C. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma. Pharmacol Res. 1999;40(1):15–29. doi:https://doi.org/10.1006/phrs.1998.0461.
- Horváth I, Hunt J, Barnes PJ, Alving K, Antczak A, Baraldi E, Becher G, van Beurden WJC, Corradi M, Dekhuijzen R, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J. 2005;26(3):523–548. doi:https://doi.org/10.1183/09031936.05.00029705.
- Samitas K, Chorianopoulos D, Vittorakis S, Zervas E, Economidou E, Papatheodorou G, Loukides S, Gaga M. Exhaled cysteinyl-leukotrienes and 8-isoprostane in patients with asthma and their relation to clinical severity. Respir Med. 2009;103(5):750–756. doi:https://doi.org/10.1016/j.rmed.2008.11.009.
- Claesson HE, Dahlen SE. Asthma and leukotrienes: antileukotrienes as novel anti-asthmatic drugs. J Intern Med. 1999;245(3):205–227. doi:https://doi.org/10.1046/j.1365-2796.1999.00418.x.
- Mikuniya T, Nagai S, Tsutsumi T, Morita K, Mio T, Satake N, Izumi T. Proinflammatory or regulatory cytokines released from BALF macrophages of healthy smokers. Respiration. 1999;66(5):419–426. doi:https://doi.org/10.1159/000029425.
- Kang S, Narazaki M, Metwally H, Kishimoto T. Historical overview of the interleukin-6 family cytokine. J Exp Med. 2020;217(5):e20190347. doi:https://doi.org/10.1084/jem.20190347.
- Yokoyama A, Kohno N, Fujino S, Hamada H, Inoue Y, Fujioka S, Ishida S, Hiwada K. Circulating interleukin-6 levels in patients with bronchial asthma. Am J Respir Crit Care Med. 1995;151(5):1354–1358. doi:https://doi.org/10.1164/ajrccm.151.5.7735584.
- Montuschi P, Barnes P, Roberts LJ. Insights into oxidative stress: the isoprostanes. Curr Med Chem. 2007;14(6):703–717. doi:https://doi.org/10.2174/092986707780059607.
- Montuschi P, Collins JV, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov SA, Barnes PJ. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med. 2000;162(3):1175–1177. doi:https://doi.org/10.1164/ajrccm.162.3.2001063.
- Shoman YWild P, Hemmendinger M, Graille M, Sauvain JJ, B Hopf N, Guseva Canu I. Reference ranges of 8-isoprostane concentrations in exhaled breath condensate (EBC): a systematic review and meta-analysis. Int J Mol Sci. 2020;21:3822. doi:https://doi.org/10.3390/ijms21113822.
- Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stres, in exhaled condansate of asthma patients. Am J Respir Crit Care Med. 1999;160(1):216–220. doi:https://doi.org/10.1164/ajrccm.160.1.9809140.
- Peel AM, Crossman-Barnes CJ, Tang J, Fowler SJ, Davies GA, Wilson AM, Loke YK. Biomarkers in adult asthma: a systematic review of 8-isoprostane in exhaled breath condensate. J Breath Res. 2017;11(1):016011. doi:https://doi.org/10.1088/1752-7163/aa5a8a.
- Gemicioglu B, Musellim B, Dogan I, Guven K. Fractional exhaled nitric oxide (FeNo) in different asthma phenotypes. Allergy Rhinol (Providence) 2014;5(3):157–161. doi:https://doi.org/10.2500/ar.2014.5.0099.
- Montuschi P. Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications. Ther Adv Respir Dis. 2007;1(1):5–23. doi:https://doi.org/10.1177/1753465807082373.
- Culver BH, Graham BL, Coates AL, Wanger J, Berry CE, Clarke PK, Hallstrand TS, Hankinson JL, Kaminsky DA, MacIntyre NR, et al. Recommendations for a standardized pulmonary function report. An official american thoracic society technical statement. Am J Respir Crit Care Med. 2017;196(11):1463–1472. doi:https://doi.org/10.1164/rccm.201710-1981ST.
- Uysal MA, Mungan D, Yorgancioglu A, Yildiz F, Akgun M, Gemicioglu B, Turktas H. The validation of the Turkish version of asthma control test. Qual Life Res. 2013;22(7):1773–1779. doi:https://doi.org/10.1007/s11136-012-0309-1.
- Ghaffari J, Rafiei AR, Ajami A, Mahdavi M, Hoshiar B. Serum interleukins 6 and 8 in mild and severe asthmatic patients, is it difference. Caspian J Intern Med. (2)2011;2:226–228.
- Carpagnano GE, Foschino Barbaro MP, Resta O, Gramiccioni E, Valerio NV, Bracciale P, Valerio G. Exhaled markers in the monitoring of airways inflammation and its response to steroid’s treatment in mild persistent asthma. Eur J Pharmacol. 2005;519(1–2):175–181. doi:https://doi.org/10.1016/j.ejphar.2005.06.034.
- Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Gramiccioni E, Barnes PJ. Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Respir J. 2003;21(4):589–593. doi:https://doi.org/10.1183/09031936.03.00022203.
- Wood LG, Baines KJ, Fu J, Scott HA, Gibson PG. The neutrophilic inflammatory phenotype is associated with systemic inflammation in asthma. Chest. 2012;142(1):86–93. doi:https://doi.org/10.1378/chest.11-1838.
- Seggev JS, Wiessner JH, Thornton WH, Jr, Edes TE. Comparison of serum and plasma leukotriene B4 levels in normal and asthma subjects. Ann Allergy Asthma Immunol. 1995;75(4):365–368.
- Mansour M, Farouk N, el Maragy A, Radwan I, el-Ahmady O. Elevated plasma level of leukotrienes in bronchial asthma patients: a possible clinical relevance . Dis Markers. 1995(2);12:117–122. doi:https://doi.org/10.1155/1994/121453.
- Montuschi P, Barnes PJ. Exhaled leukotrienes and prostaglandins in asthma. J Allergy Clin Immunol. 2002;109(4):615–620. doi:https://doi.org/10.1067/mai.2002.122461.
- Garey KW, Neuhauser MM, Robbins RA, Danziger LH, Rubinstein I. Markers of inflammation in exhaled breath condansate of young healthy smokers. Chest. 2004;125(1):22–26. doi:https://doi.org/10.1378/chest.125.1.22.
- Celik D, Doruk S, Koseoglu HI, Sahin S, Celikel S, Erkorkmaz U. Cysteinyl leukotrienes in exhaled breath condensate of smoking asthmatics. Clin Chem Lab Med. 2013;51(5):1069–1073. doi:https://doi.org/10.1515/cclm-2012-0479.
- Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Garg ML. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma. Lipids. 2000;35(9):967–974. doi:https://doi.org/10.1007/s11745-000-0607-x.
- Mak JCW, Ho SP, Ho ASS, Law BKW, Cheung AHK, Ho JCM, Ip MSM, Chan-Yeung MMW. Sustained elevation of systemic oxidative stress and inflammation in exacerbation and remission of asthma. ISRN Allergy. 2013;2013:561831. doi:https://doi.org/10.1155/2013/561831.
- Piotrowski WJ, Majewski S, Marczak J, Kurmanowska Z, Górski P, Antczak A. Exhaled breath 8-isoprostane as a marker of asthma severity. Arch Med Sci. 2012;8(3):515–520. doi:https://doi.org/10.5114/aoms.2012.28639.
- Xu DP, Li Y, Meng X, Zhou T, Zhou Y, Zheng J, Zhang JJ, Li HB. Natural antioxidants in foods and medicinal plants: extraction, assessment and resources. Int J Mol Sci. 2017;18:96. doi:https://doi.org/10.3390/ijms18010096.
- Liang S, Wei X, Gong C, Wei J, Chen Z, Chen X, Wang Z, Deng J. Significant association between asthma risk and the GSTM1 and GSTT1 deletion polymorphisms: an updated meta-analysis of case-control studies. Respirology. 2013;18(5):774–783. doi:https://doi.org/10.1111/resp.12097.
- Papamichael MM, Katsardis C, Sarandi E, Georgaki S, Frima ES, Varvarigou A, Tsoukalas D. Application of metabolomics in pediatric asthma: prediction, diagnosis and personalized treatment. Metabolites. 2021;11:251. doi:https://doi.org/10.3390/metabo11040251.
- Krantz C, Janson C, Alving K, Malinovschi A. Nasal nitric oxide in relation to asthma characteristics in a longitudinal asthma cohort study. Nitric Oxide. 2021;106:1–8. doi:https://doi.org/10.1016/j.niox.2020.09.002.